Posted on August 18, 2008 by cartier@bio
In St. Louis, another small biotech firm is contemplating what steps to take if the SBIR bill is not renewed soon. Currently, Kereos Inc., a 15-employee company studying promising new methods of detecting and treating cancer is excluded from the SBIR program. This piece in Sunday’s St. Louis Post Dispatch illustrates the struggles that many [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: SBIR, BIO, biotech, VC, House Small Business Committee, Senate, Mark Heesen | No Comments »
Posted on August 11, 2008 by cartier@bio
The Senate Small Business Committee has passed an SBIR reauthorization bill. We hope the House and Senate will work together to pass a final reauthorization bill before this program is set to expire on September 30, 2008.
From the Puget Sound Business Journal:
Under a compromise negotiated in the U.S. Senate, small companies that are majority-owned [...]
Filed under: BIO, Congress, In the News, SBIR, venture capital | Tagged: SBIR, NIH, BIO, vc-owned firms, SBA, VC, Senate Small Business Committee, Biotechnology industry, Jim Greenwood | No Comments »
Posted on July 9, 2008 by cartier@bio
With three weeks remaining before the August recess, time is running short for the Senate to continue to meet regarding the SBIR bill. (NOTE: the House passed a SBIR reauthorization bill in April). Yesterday the Wall Street Journal ran a piece outlining the debate on who should receive these SBIR grants: Should a small business [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: SBIR, venture capital, House, VC, Wall Street Journal, Senate | No Comments »
Posted on June 26, 2008 by cartier@bio
Hopes and Cures spokes to John Risner, President of The Children’s Tumor Foundation about the group’s work, in particular about funding for research. CTF is a non-profit 501(c) (3) medical foundation, dedicated to improving the health and well being of individuals and families affected by the neurofibromatosis (NF).
ABOUT NF
Neurofibromatosis (NF) is the term for [...]
Filed under: Finding Cures, SBIR, patient groups, venture capital | Tagged: CCF, children's tumor Foundation, Drug Discovery, NF, research, Tumors, VC | 1 Comment »
Posted on June 19, 2008 by cartier@bio
Recently, there was an interesting study conducted by PricewaterhouseCoopers, the New England Healthcare Institute, the Massachusetts Life Sciences Center, Xconomy and the Massachusetts Technology Collaborative on the Massachusetts Life Sciences Super Cluster, showing the value of a strong science sector economically. This Super Cluster includes Universities, teaching hospitals, biotechnology, medical device, and pharmaceutical companies. Software, [...]
Filed under: BIO, In the News, SBIR, venture capital | Tagged: biotech, MA, Pricewaterhouse, Study, VC | No Comments »
Posted on June 11, 2008 by cartier@bio
SBIR Stories
Free Money Myths from the Government
Give Me Fish nets Phase 0 award
Blog Posts
Venture Capital Alternatives: SBIR
Just How Short-sighted is the VC Community?
NIH SBIR Comes to Atlanta
Filed under: In the News, SBIR, venture capital | Tagged: SBIR, NIH, VC, Atlanta | No Comments »
Posted on April 14, 2008 by cartier@bio
Fortune Small Business Volume 18; Issue 3
Funding research to develop cures for life-saving diseases is not a laughing matter, and we shouldn’t be making public policy based on cartoons. Small biotechnology companies, like the innovative and fast-thinking Jerry of the Tom & Jerry cartoon, deserve to succeed, but it’s the Small Business Administration that is [...]
Filed under: Congress, In the News, SBIR | Tagged: angel funding, SBA, Small Business Technology Coalition, VC | No Comments »
cartier@bio
nicoleatbio
